LEMAITRE VASCULAR, INC. Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31)
LEMAITRE VASCULAR, INC. (LMAT) reported Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) of $1.42 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-27.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitContinuingOperations · last filed 2013-03-27
- LEMAITRE VASCULAR, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2012 was $1.42M, a 11.62% decline from fiscal 2011.
- LEMAITRE VASCULAR, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2011 was $1.61M.
- LEMAITRE VASCULAR, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2010 was -$1.99M.
| Period end | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-12-31 | $1.42M 10-K · filed 2013-03-27 |
| 2011-12-31 | $1.61M 10-K · filed 2013-03-27 |
| 2010-12-31 | -$1.99M 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |